• Research Support

Research At the QuintilesIMS Institute

The QuintilesIMS Institute comprises researchers who are conducting empirically rigorous, policy-relevant studies to improve the quality and cost-effectiveness of healthcare. The QuintilesIMS Institute includes members from a variety of disciplines including pharmacy, medicine, law, economics, business, and public policy.

Recently completed projects range from an examination of off-label prescribing among office-based physicians to an analysis of the impact of FDA safety advisories on prescription drug utilization to a study of the influence of patent expiration on the use of antibiotics.

Shaping the Future of Healthcare

Through collaboration with the QuintilesIMS Institute, researchers and students have access to a broad range of proprietary databases and tools to support independent research, discovery work and requirement development for future funded studies.

Research Priorities

Although the QuintilesIMS Institute for Healthcare Informatics welcomes proposals examining most aspects of healthcare, projects that are directly relevant to ongoing healthcare reform are of greatest interest. High-priority areas include:

Comparative Effectiveness Research

  • Evaluations of which interventions work best, for whom, and under what circumstances
  • Analyses of how comparative effectiveness research is reflected in clinical practice

Drug Utilization Trends and Expenditures

  • Analysis of national trends in prescription drug utilization and office-based care
  • Examination of adoption of new therapies among patient and physician subpopulations
  • Evaluation of prescription use and expenditures and factors that influence these trends

Real-world Practice

  • Analysis of association between patient, physician, and health system characteristics and practice patterns
  • Establishment of best practices and quality metrics for specific conditions or populations, including for preventive care and screening
  • Utilization trends and costs in specific medical areas, such as oncology, cardiovascular disease or rare diseases where orphan drugs or specialty drugs are used
  • Investigations of socioeconomic, racial, or ethnic disparities in processes or outcomes of care

Geographic Variations in Care

  • Examination of geographic variations in treatments, costs and outcomes
  • Ecologic studies examining how geographic variation in prescription use (e.g., antibiotics) is associated with specific outcomes (e.g., antimicrobial resistance)
  • Studies using geographic variation in use to infer information regarding disease or treatment prevalence

To learn more about ways that the QuintilesIMS Institute can support your initiatives, please reach out to our team: